- Home
- RNAZ vs ZAPP Comparison
RNAZ vs ZAPP Comparison
Compare RNAZ & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- ZAPP
- Stock Information
- Founded
- RNAZ 2016
- ZAPP 2017
- Country
- RNAZ United States
- ZAPP Thailand
- Employees
- RNAZ N/A
- ZAPP N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- ZAPP Motor Vehicles
- Sector
- RNAZ Health Care
- ZAPP Consumer Discretionary
- Exchange
- RNAZ Nasdaq
- ZAPP Nasdaq
- Market Cap
- RNAZ 7.2M
- ZAPP 7.0M
- IPO Year
- RNAZ 2021
- ZAPP N/A
- Fundamental
- Price
- RNAZ $0.53
- ZAPP $0.70
- Analyst Decision
- RNAZ Strong Buy
- ZAPP
- Analyst Count
- RNAZ 1
- ZAPP 0
- Target Price
- RNAZ $20.00
- ZAPP N/A
- AVG Volume (30 Days)
- RNAZ 16.6M
- ZAPP 150.2K
- Earning Date
- RNAZ 05-14-2025
- ZAPP 01-31-2025
- Dividend Yield
- RNAZ N/A
- ZAPP N/A
- EPS Growth
- RNAZ N/A
- ZAPP N/A
- EPS
- RNAZ N/A
- ZAPP N/A
- Revenue
- RNAZ N/A
- ZAPP $17,440.00
- Revenue This Year
- RNAZ $180.81
- ZAPP $67,159.17
- Revenue Next Year
- RNAZ N/A
- ZAPP $1,149.53
- P/E Ratio
- RNAZ N/A
- ZAPP N/A
- Revenue Growth
- RNAZ N/A
- ZAPP N/A
- 52 Week Low
- RNAZ $0.43
- ZAPP $0.66
- 52 Week High
- RNAZ $66.33
- ZAPP $19.10
- Technical
- Relative Strength Index (RSI)
- RNAZ 28.52
- ZAPP 36.54
- Support Level
- RNAZ $0.43
- ZAPP $0.66
- Resistance Level
- RNAZ $0.61
- ZAPP $0.92
- Average True Range (ATR)
- RNAZ 0.17
- ZAPP 0.08
- MACD
- RNAZ 0.21
- ZAPP -0.02
- Stochastic Oscillator
- RNAZ 8.24
- ZAPP 11.60
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories. Companies founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. The company operates in Cayman Islands, Europe, Thailand. Maximum of revenue is from Thailand.